Bioasis Technologies

Bioasis establishes U.S. presence with office in Connecticut

Wednesday, October 11, 2017

Bioasis Technologies, a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier (BBB) and into the central nervous system for the treatment of neurological diseases and disorders, announced the establishment of its U.S. office in Guilford, Conn. Additionally, the company has launched its new corporate website,

[Read More]